Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer

Summary

This study investigates the efficacy of neoadjuvant radiotherapy combined with QL1706 in MSS-type low-grade rectal cancer. This study is a prospective multicohort study, with cohort 1 intended to include patients with low grade early rectal cancer (cT1-3N0M0) and cohort 2 intended to include patients with low grade locally advanced rectal cancer (cT4N0M0 or cTanyN+M0). Each cohort included 30 subjects receiving neoadjuvant radiotherapy combined with QL1706 treatment.

Timeline

Start

2025-05-20

Primary completion

2028-03-01

Completion

2035-03-01

Drugs

Indications